Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole

Molecular Pharmacology

Volumn 63, Issue 5, 2003, Pages 1137-1147

  Carr, Brian A ^a   Ramakanth, Swayampakula ^a,b   Dannan, Ghazi A ^a,c   Yost, Garold S ^a  

^a UNIVERSITY OF UTAH   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 4B2; CYTOCHROME P450 ISOENZYME; HEME; MUTANT PROTEIN; RECOMBINANT ENZYME; SKATOLE; UNCLASSIFIED DRUG;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYST; ELECTROPHORESIS; ENZYME ANALYSIS; ENZYME BINDING; ENZYME ISOLATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME PURIFICATION; ESCHERICHIA COLI; FEMALE; GOAT; HYDROXYLATION; ION EXCHANGE CHROMATOGRAPHY; LUNG TOXICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; RABBIT; RAT; TISSUE DISTRIBUTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CATALYSIS; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; ESCHERICHIA COLI; FEMALE; FLUORENES; GENE LIBRARY; GOATS; HYDROXYLATION; LUNG; MICROSOMES; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; SKATOLE;

EID: 0038644585     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.5.1137     Document Type: Article

References (54)

1. Adams JD Jr, Laegreid WW, Huijzer JC, Hayman C, and Yost GS (1988) Pathology and glutathione status in 3-methylindole-treated rodents. Res Commun Chem Pathol Pharmacol 60:323-336.
2. Barnes HJ (1996) Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli. Methods Enzymol 272:3-14.
3. Barnes HJ, Arlotto MP, and Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc Natl Acad Sci USA 88:5597-5601.
4. Belanger PM, Grech-Belanger O, and Blouin M (1981) Colorimetric determination of N-hydroxylated metabolites in microsomal studies. Anal Biochem 118:47-52.
5. Boyd MR (1984) Metabolic activation and lung toxicity: a basis for cell-selective pulmonary damage by foreign chemicals. Environ Health Perspect 55:47-51.
6. Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, and Gonzalez FJ (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96:1977-1982.
7. Bylund J, Finnstrom N, and Oliw EH (1999) Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles. Biochem Biophys Res Commun 261:169-174.
8. Carlson JR, Dyer IA, and Johnson RJ (1968) Tryptophan-induced interstitial pulmonary emphysema in cattle. Am J Vet Res 29:1983-1989.
9. Carlson JR and Yost GS (1989) 3-Methylindole-induced acute lung injury re-sulting from ruminal fermentation of tryptophan, in Toxicants of Plant Origin: Proteins and Amino Acids (Cheeke PR ed) pp 107-123, CRC Press, Boca Raton.
10. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Czerwinski M, McLemore TL, Gelboin HV, and Gonzalez FJ (1994) Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 54:1085-1091.
12. Ding X and Kaminsky LS (2003) Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173.
13. Domin BA, Devereux TR, and Philpot RM (1986) The cytochrome P-450 monooxygenase system of rabbit lung enzyme components, activities, and induction in the nonciliated bronchiolar epithelial (Clara) cell, alveolar type II cell and alveolar macrophage. Mol Pharmacol 30:296-303.
14. Gram TE (1997) Chemically reactive intermediates and pulmonary xenobiotic toxicity. Pharmacol Rev 49:297-341.
15. Guengerich FP, Dannan GA, Wright ST, Martin MV, and Kaminsky LS (1982) Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or betanaphthoflavone. Biochemistry 21:6019-6030.
16. Henne KR, Kunze KL, Zheng YM, Christmas P, Soberman RJ, and Rettie AE (2001) Covalent linkage of prosthetic heme to CYP4 family P450 enzymes. Biochemistry 40:12925-12931.
17. Hoffmann D and Rathkamp G (1970) Quantitative determination of 1-alkylindoles in cigarette smoke. Anal Chem 42:366-370.
18. Huijzer JC, Adams JD Jr, Jaw JY, and Yost GS (1989) Inhibition of 3-methylindole bioactivation by the cytochrome P-450 suicide substrates 1-aminobenzotriazole and alpha-methylbenzylaminobenzotriazole. Drug Metab Dispos 17:37-42.
19. Imaoka S, Hayashi K, Hiroi T, Yabusaki Y, Kamataki T, and Funae Y (2001) A transgenic mouse expressing human CYP4B1 in the liver. Biochem Biophys Res Commun 284:757-762.
20. Imaoka S, Yoneda Y, Sugimoto T, Hiroi T, Yamamoto K, Nakatani T, and Funae Y (2000) CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem Biophys Res Commun 277:776-780.
21. Iwata H, Fujita K, Kushida H, Suzuki A, Konno Y, Nakamura K, Fujino A, and Kamataki T (1998) High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem Pharmacol 55:1315-1325.
22. Kaminsky LS, Fasco MJ, and Guengerich FP (1981) Production and application of antibodies to rat liver cytochrome P-450. Methods Enzymol 74:262-272.
23. Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, and Raunio H (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 57:1407-1413.
24. Lanza DL, Code E, Crespi CL, Gonzalez FJ, and Yost GS (1999) Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798-803.
25. Lanza DL and Yost GS (2001) Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes. Drug Metab Dispos 29:950-953.
26. LeBrun LA, Hoch U, and Ortiz de Montellano PR (2002a) Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A family. J Biol Chem 277:12755-12761.
27. LeBrun LA, Xu F, Kroetz DL, and Ortiz de Montellano PR (2002b) Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 family. Bio. chemistry 41:5931-5937.
28. Lo-Guidice JM, Allorge D, Cauffiez C, Chevalier D, Lafitte JJ, Lhermitte M, and Broly F (2002) Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant. Pharmacogenetics 12:367-374.
29. Nhamburo PT, Gonzalez FJ, McBride OW, Gelboin HV, and Kimura S (1989) Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression and chromosome mapping. Biochemistry 28:8060-8066.
30. Nichols WK, Larson DN, and Yost GS (1990) Bioactivation of 3-methylindole by isolated rabbit lung cells. Toxicol Appl Pharmacol 105:264-270.
31. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
32. Parandoosh Z, Fujita VS, Coon MJ, and Philpot RM (1987) Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver. Comparisons of structure and inducibility. Drug Metab Dispos 15:59-67.
33. Parikh A, Gillam EM, and Guengerich FP (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol 15:784-788.
34. Phillips AH and Langdon RG (1962) Hepatic triphosphopyridine nucleotidecytochrome c reductase: isolation, characterization and kinetic studies. J Biol Chem 237:2652-2660.
35. Ramakanth S, Thornton-Manning JR, Wang H, Maxwell H, and Yost GS (1994) Correlation between pulmonary cytochrome P450 transcripts and the organ-selective pneumotoxicity of 3-methylindole. Toxicol Lett 71:77-85.
36. Rettie AE, Boberg M, Rettenmeier AW, and Baillie TA (1988) Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects and mechanistic studies. J Biol Chem 263:13733-13738.
37. Rettie AE, Sheffels PR, Korzekwa KR, Gonzalez FJ, Philpot RM, and Baillie TA (1995) CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid. Biochemistry 34:7889-7895.
38. Schulze J, Richter E, and Philpot RM (1990) Tissue, species and substrate concentration differences in the position-selective hydroxylation of N-nitrosodibutylamine. Relationship to the distribution of cytochrome P-450 isozymes 2 (IIB) and 5 (IVB). Drug Metab Dispos 18:398-402.
39. Serabjit-Singh CJ, Wolf CR, and Philpot RM (1979) The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J Biol Chem 254:9901-9907.
40. Shephard EA, Pike SF, Rabin BR, and Phillips IR (1983) A rapid one-step purification of NADPH-cytochrome c (P-450) reductase from rat liver microsomes. Anal Biochem 129:430-433.
41. Skiles GL and Yost GS (1996) Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole. Chem Res Toxicol 9:291-297.
42. Skordos KW, Laycock JD, and Yost GS (1998a) Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole. Chem Res Toxicol 11:1326-1331.
43. Skordos KW, Skiles GL, Laycock JD, Lanza DL, and Yost GS (1998b) Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methylindole. Chem Res Toxicol 11:741-749.
44. Thornton-Manning J, Appleton ML, Gonzalez FJ, and Yost GS (1996) Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. J Pharmacol Exp Ther 276:21-29.
45. ThorntonManning JR, Ruangyuttikarn W, Gonzalez FJ, and Yost GS (1991) Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s. Biochem Biophys Res Commun 181:100-107.
46. Turk MA, Flory W, and Henk WG (1984) Dose response in 3-methylindole-induced bronchiolar epithelial necrosis in mice. Res Commun Chem Pathol Pharmacol 46:351-362.
47. Turk MA, Flory W, and Henk WG (1986) Chemical modulation of 3-methylindole toxicosis in mice: effect on bronchiolar and olfactory mucosal injury. Vet Pathol 23:563-570.
48. Vanderslice RR, Domin BA, Carver GT, and Philpot RM (1987) Species-dependent expression and induction of homologues of rabbit cytochrome P-450 isozyme 5 in liver and lung. Mol Pharmacol 31:320-325.
49. Wang H, Lanza DL, and Yost GS (1998) Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch Biochem Biophys 349:329-340.
50. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, and Korzekwa K (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 290:160-166.
51. Windmill KF, McKinnon RA, Zhu X, Gaedigk A, Grant DM, and McManus ME (1997) The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat Res 376:153-160.
52. Yost GS (1989) Mechanisms of 3-methylindole pneumotoxicity. Chem Res Toxicol 2:273-279.
53. Yost GS (1997) Selected, non-therapeutic agents, in Comprehensive Toxicology (Sipes IG, McQueen CA, and Gandolfi AJ eds) pp 591-610, Elsevier Science, Oxford.
54. Zheng YM, Fisher MB, Yokotani N, Fujii-Kuriyama Y, and Rettie AE (1998) Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1. Biochemistry 37:12847-12851.